By Regulatory Approvals — US FDA approves Roche's Gazyva as first treatment for primary membranous nephropathy Dealroom
Read the original at Regulatory Approvals ↗
Auto-published by the finit.news Events monitor from Regulatory Approvals; summarized by AI and may contain errors — verify against the primary source. November 14, 2026.